Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-01-05
1988-07-26
Brust, Joseph Paul
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544216, 544238, 544296, 544333, 544336, 544357, 546256, C07D20934, A61K 3140
Patent
active
047600837
ABSTRACT:
Cognitive deficiencies and/or neurological function deficits and/or mood and/or mental disturbances are treated by the administration of 3,3-disubstituted indolines. The indolines have the formula: ##STR1## wherein: p is 0 or 1;
REFERENCES:
patent: 3574232 (1971-04-01), Canas-Rodriguez et al.
patent: 4273860 (1981-06-01), Adin
patent: 4372960 (1983-02-01), L'Italien
patent: 4434169 (1984-02-01), Poschel et al.
patent: 4452990 (1984-06-01), Butler
Abstract of Japan 59-098896A; Nippon Telegraph & Telephone, (Original Patent Dated Jun. 7, 1984).
Adin, et al.; Research Disclosures, 184, (1979), pp. 446-454.
Daisley, et al.; J. Heterocyclic Chem., 19, (1982), pp. 1013-1016.
Ogata, et al.; Eur. J. Med. Chem., Chem. Ther, (1981), 16(4), pp. 373-378.
Myers Melvyn J.
Nickolson Victor J.
Black Robert W.
Brust Joseph Paul
E. I. Dupont de Nemours & Company
LandOfFree
3,3-disubstituted indolines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3,3-disubstituted indolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3,3-disubstituted indolines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-258196